Literature DB >> 24391197

Assessment of microbiological diagnostic procedures for respiratory specimens from cystic fibrosis patients in German laboratories by use of a questionnaire.

Laura Häfner1, Georg Peters, Barbara C Kahl.   

Abstract

Respiratory specimens from cystic fibrosis (CF) patients challenge microbiological laboratories with their complexity of pathogens and atypical variants. We evaluated the diagnostic procedures in German laboratories by use of a questionnaire. Although most laboratories followed guidelines, some of them served only a small number of patients, while others did not use the recommended selective agars to culture the particular CF-relevant species.

Entities:  

Mesh:

Year:  2014        PMID: 24391197      PMCID: PMC3957798          DOI: 10.1128/JCM.02866-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Validation of Vitek 2 nonfermenting gram-negative cards and Vitek 2 version 4.02 software for identification and antimicrobial susceptibility testing of nonfermenting gram-negative rods from patients with cystic fibrosis.

Authors:  Ines Otto-Karg; Stefanie Jandl; Tobias Müller; Beate Stirzel; Matthias Frosch; Helge Hebestreit; Marianne Abele-Horn
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

2.  DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III.

Authors:  E Mahenthiralingam; J Bischof; S K Byrne; C Radomski; J E Davies; Y Av-Gay; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

3.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

4.  Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis.

Authors:  P H Gilligan; P A Gage; L M Bradshaw; D V Schidlow; B T DeCicco
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

5.  Evaluation of S. aureus ID, a new chromogenic agar medium for detection of Staphylococcus aureus.

Authors:  John D Perry; Claire Rennison; Lynne A Butterworth; Andrew L J Hopley; F Kate Gould
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

Review 6.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

7.  Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis.

Authors:  P H Gilligan; P A Gage; D F Welch; M J Muszynski; K R Wait
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

8.  EuroCareCF quality assessment of diagnostic microbiology of cystic fibrosis isolates.

Authors:  Michael Hogardt; Jutta Ulrich; Helga Riehn-Kopp; Burkhard Tümmler
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

9.  Population dynamics of persistent Staphylococcus aureus isolated from the airways of cystic fibrosis patients during a 6-year prospective study.

Authors:  Barbara C Kahl; Angelika Duebbers; Gabriele Lubritz; Johannes Haeberle; Hans G Koch; Barbara Ritzerfeld; Marion Reilly; Erik Harms; Richard A Proctor; Mathias Herrmann; Georg Peters
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948

10.  Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis.

Authors:  O C Tablan; L A Carson; L B Cusick; L A Bland; W J Martone; W R Jarvis
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

View more
  2 in total

1.  Microbiological diagnostic procedures for respiratory cystic fibrosis samples in Spain: towards standard of care practices.

Authors:  Juan de Dios Caballero; Rosa del Campo; Marta Tato; Elia Gómez G de la Pedrosa; Marta Cobo; Carla López-Causapé; Enrique Gómez-Mampaso; Antonio Oliver; Rafael Cantón
Journal:  BMC Microbiol       Date:  2014-12-24       Impact factor: 3.605

2.  Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus.

Authors:  Sibylle Junge; Dennis Görlich; Martijn den Reijer; Bärbel Wiedemann; Burkhard Tümmler; Helmut Ellemunter; Angelika Dübbers; Peter Küster; Manfred Ballmann; Cordula Koerner-Rettberg; Jörg Große-Onnebrink; Eberhardt Heuer; Wolfgang Sextro; Jochen G Mainz; Jutta Hammermann; Joachim Riethmüller; Ute Graepler-Mainka; Doris Staab; Bettina Wollschläger; Rüdiger Szczepanski; Antje Schuster; Friedrich-Karl Tegtmeyer; Sivagurunathan Sutharsan; Alexandra Wald; Jerzy-Roch Nofer; Willem van Wamel; Karsten Becker; Georg Peters; Barbara C Kahl
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.